Acute lymphoblastic leukaemia.
Malard F, Mohty M.
Lancet. 2020 Apr 4;395(10230):1146-1162. doi: 10.1016/S0140-6736(19)33018-1.
Predicting relapse in acute lymphoblastic leukemia.
Schwartz MS, Muffly LS.
Leuk Lymphoma. 2024 Dec;65(13):1934-1940. doi: 10.1080/10428194.2024.2387728. Epub 2024 Aug 31.
[Acute lymphoblastic leukemia: pathophysiology and current therapy].
Imai K.
Rinsho Ketsueki. 2017;58(5):460-470. doi: 10.11406/rinketsu.58.460.
Acute lymphoblastic leukemia.
Chan KW.
Curr Probl Pediatr Adolesc Health Care. 2002 Feb;32(2):40-9. doi: 10.1067/mps.2002.121790.
IKZF1 in acute lymphoblastic leukemia: the rise before the fall?
Østergaard A, Boer JM, van Leeuwen FN, Pieters R, Den Boer ML.
Leuk Lymphoma. 2024 Dec;65(14):2077-2087. doi: 10.1080/10428194.2024.2396046. Epub 2024 Aug 29.
Acute lymphoblastic leukemia.
Onciu M.
Hematol Oncol Clin North Am. 2009 Aug;23(4):655-74. doi: 10.1016/j.hoc.2009.04.009.
Acute lymphoblastic leukemia.
Farhi DC, Rosenthal NS.
Clin Lab Med. 2000 Mar;20(1):17-28, vii.
Developing Targeted Therapies for T Cell Acute Lymphoblastic Leukemia/Lymphoma.
DuVall AS, Wesevich A, Larson RA.
Curr Hematol Malig Rep. 2023 Dec;18(6):217-225. doi: 10.1007/s11899-023-00706-7. Epub 2023 Jul 25.
[Acute lymphoblastic leukemia].
Usui N.
Rinsho Ketsueki. 2009 Apr;50(4):230-43.
Recurrent Cytogenetic Abnormalities in Acute Lymphoblastic Leukemia.
Shago M.
Methods Mol Biol. 2017;1541:257-278. doi: 10.1007/978-1-4939-6703-2_21.
